Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Workers' Comp
Podcast
Why Opioid Trends Are Changing in Workers’ Comp
Workers' Comp
Article
Ask The Pharmacist: Biologics and Approved Biosimilar Drugs in Workers’ Compensation
What are biological and biosimilar drugs? It is likely you have heard the terms biological o
Workers' Comp
Case Study
Achieve Operational Excellence
Workers' Comp
Article
Vocational Considerations for Referral to Field Case Management
When physical limitations, education, work history, or job-seeking skills pose a hurdle for injured employees, a field case management referral can
Law.com
Article
Opioids Situation Improves, But Workers’ Comp Pharmacy Faces New Challenges
In workers’ comp pharmacy management, opioids often get the lion’s share of attention, and for good reason.
Risk & Insurance
In the News